India Chronic Disease Management Solutions Market Research Report: Forecast (2026-2032)

India Chronic Disease Management Solutions Market Report Key Takeaways

• The India Chronic Disease Management Solutions Market size was valued at around USD 689 million in 2025 and is projected to reach USD 1419 million by 2032. The estimated CAGR from 2026 to 2032 is around 10.87%, indicating strong growth.
• By Patient Age Group, the 36 to 50 age group segment holds a 29% share of the India Chronic Disease Management Solutions Market size in 2025.
• By Disease Indication, diabetes represented a 35% share of the India Chronic Disease Management Solutions Market size in 2025.
• By Care Type, facility-based clinical management represented 67% of the India Chronic Disease Management Solutions Market size in 2025.
• By Patient Location, the Urban segment seized around 57% share of the India Chronic Disease Management Solutions Market size in 2025.
• By Region, North India leads the India Chronic Disease Management Solutions Market with a dominant share of around 34% share in 2025.
• The leading chronic disease management solutions companies in India are BeatO, HealthifyMe, Wellthy Therapeutics, NanoHealth, Cipla, Nivaancare, Fitterfly, Sun Pharmaceuticals, Apollo Hospitals, and others.

Market Insights & Analysis: India Chronic Disease Management Solutions Market (2026-2032):

The India Chronic Disease Management Solutions Market was valued at around USD 689 million in 2025 and is projected to reach USD 1419 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 10.87% during the forecast period, i.e., 2026-32.

The India Chronic Disease Management Solutions Market is experiencing rapid growth, driven by propelled by a sharp increase in chronic disease prevalence and the growing deployment of AI-powered screening and predictive diagnostics. These advancements are enhancing patient monitoring, enabling earlier clinical intervention, and strengthening long-term care coordination nationwide.

Recent findings from the World Health Organization indicate that hypertension now affects more than 210 million adults in India, accounting for over 30% of the adult population, with prevalence rising due to demographic ageing and lifestyle transitions.

State-led public-health campaigns echo this trend. For instance, Chhattisgarh screened more than 7.5 million people for diabetes and high blood pressure in the first seven months of 2025, underscoring the scale of population-level risk assessment currently underway.

National datasets, including findings from the National Family Health Survey (NFHS-5) and government self-reported records, continue to reflect hypertension prevalence of around 32% and diabetes prevalence of nearly 14% among adults, alongside growing cases of cardiovascular disorders and chronic respiratory conditions.

Within this context, AI-enabled screening and predictive diagnostics are emerging as key growth accelerators for the CDM market. For example, under the National Tuberculosis Elimination Programme, AI-supported screening tools have already been applied to more than 162,000 individuals, leading to a 12–16% improvement in case detection compared with conventional methods. These deployments signal a broader governmental shift toward technology-supported surveillance, automated triage, and early-stage clinical intervention, which is expected to stimulate demand for digital monitoring platforms and integrated chronic-care solutions.

Future policy initiatives are also likely to reinforce this trajectory. For instance, in 2025, the Ministry of Health and Family Welfare launched the Intensified Special Non-Communicable Disease Screening Drive, targeting 100% screening of all Indians aged 30 years and above for diabetes, hypertension, and common cancers through door-to-door outreach by Accredited Social Health Activists and Auxiliary Nurse Midwives, with the programme expected to expand beyond 2025 through data-driven follow-ups and surveillance.

Continued alignment with the National Health Policy 2017, the National Programme for Prevention and Control of Non-Communicable Diseases, and Sustainable Development Goal Target 3.4 further strengthens long-term commitments to preventive care and integrated health delivery.

Facility-based clinical management accounted for 67% of the India Chronic Disease Management Solutions Market in 2025, reaffirming the central role of hospitals and specialty centers in coordinated, multidisciplinary chronic-care delivery. Meanwhile, urban patients represented 57% of market demand, driven by higher diagnosis rates, stronger digital-health adoption, and broader access to AI-enabled screening and specialty-care infrastructure.

Rising chronic-disease prevalence, coupled with expanding AI-enabled screening and proactive government initiatives, is expected to significantly accelerate the adoption of advanced Chronic Disease Management solutions, reinforcing their central role in India’s evolving, prevention-focused healthcare landscape.

India Chronic Disease Management Solutions Market Recent Developments:

• December 2025: The Armed Forces Medical Services (AFMS) has begun rolling out an AI-based diabetic eye screening programme across cities such as Pune, Mumbai, Bengaluru, and Kochi to improve early detection of diabetic retinopathy, a leading cause of preventable blindness among diabetics. The initiative, using the MadhuNetrAI platform, enables automated retinal imaging and analysis to identify at-risk patients and connect them with care pathways.
• February 2025: Lillia, an AI health tech startup, has introduced a clinically validated chronic disease management platform that combines artificial intelligence with expert human coaching to help individuals living with diabetes and related conditions achieve better health outcomes. The initiative was supported by a USD 1.7 million grant from the Qatar Research, Development, and Innovation Council to develop digital twin technology and predictive care capabilities. 

India Chronic Disease Management Solutions Market Scope:

India Chronic Disease Management Solutions Market Drivers:

Rising Chronic Disease Burden Augmenting Market Growth

India’s steadily rising burden of chronic diseases is becoming a decisive driver for the expansion of Chronic Disease Management solutions. Official government health records indicate that Non-Communicable Diseases (NCDs), particularly hypertension and diabetes, now represent one of the country’s most significant public-health challenges.

In response, the Government of India launched the “75/25 Initiative” in 2023, which aims to place 75 million individuals diagnosed with hypertension or diabetes under standardized clinical care by December 2025.

Progress has been substantial by March 2025, 42.01 million hypertension patients and 25.27 million diabetes patients had already been enrolled in structured treatment pathways, underscoring the growing scale of long-term disease management in the country.

Government figures from early 2025 further highlight the expanding caseload, reporting more than 11.1 million newly diagnosed hypertension cases and 6.4 million newly identified diabetes cases brought under treatment during the first half of the year. These outcomes reflect intensified nationwide screening, stronger surveillance mechanisms, and increasing emphasis on the principle that “prevention is better than cure.”

The sustained rise in chronic disease prevalence is reinforcing the strategic importance of preventive care and structured disease monitoring in India. This driver is expected to significantly strengthen demand for advanced Chronic Disease Management solutions, making them integral to the country’s evolving healthcare ecosystem in the years ahead.

India Chronic Disease Management Solutions Market Trends:

Inclination Towards AI-Enabled Screening and Early Risk Detection

India is witnessing a strong shift toward Artificial Intelligence (AI) enabled screening and early risk detection, which has become a defining trend in the Chronic Disease Management ecosystem.

A major advancement in this trend is MadhuNETrAI, developed by the All India Institute of Medical Sciences with support from the Ministry of Health and Family Welfare’s e-Health division and Wadhwani AI. As India’s first fully validated AI mobile app for diabetic retinopathy detection, it delivers over 95% accuracy, enabling frontline health workers to rapidly identify high-risk patients without an on-site ophthalmologist, improving early screening efficiency.

The Ministry of Health and Family Welfare has also begun embedding AI across national health programmes. MadhuNETrAI is currently operational in 38 facilities across 11 states, where it has processed more than 14,000 retinal images and assisted over 7,100 patients in timely risk assessment. Meanwhile, AI capabilities integrated into the eSanjeevani telemedicine platform have supported more than 282 million consultations, improving structured clinical data capture and enabling AI-assisted differential diagnosis.

As AI-enabled tools expand across public-health programmes, India is strengthening proactive diagnosis, timely intervention, and care-continuity mechanisms, a transformation that will significantly accelerate the adoption and growth of advanced Chronic Disease Management solutions in the coming years.

India Chronic Disease Management Solutions Market Challenges:

Fragmented Healthcare Ecosystem & Lack of Interoperable Data System

A key challenge for the India Chronic Disease Management Solutions Market is the fragmented healthcare ecosystem and lack of interoperable data systems. Despite progress under the Ayushman Bharat Digital Mission, many facilities still function on standalone platforms, causing gaps in patient records, weak care coordination, and duplication of diagnostics. Legacy systems, uneven digital adoption, and inconsistent data standards continue to restrict seamless information exchange and hinder efficient, integrated chronic care delivery.

The challenge is visible at the state level as well, for instance, in Rajasthan, only about 1.2 crore out of 6.2 crore Ayushman Bharat Health Account (ABHA) IDs are linked to comprehensive electronic records, restricting the functional value of digital health identifiers.

Further, limited Electronic Health Record (EHR) standardization and slow adoption hinder population-level analytics and chronic disease surveillance, despite national roadmaps such as the National Digital Health Blueprint.

Persistent data silos and fragmented health information flows weaken the effectiveness of chronic disease management platforms. Unless interoperable data exchange and unified EHR standards are fully implemented, scalability, care integration, and market expansion will remain constrained.

India Chronic Disease Management Solutions Market (2026-32) Segmentation Analysis:

The India Chronic Disease Management Solutions Market Report and Forecast 2026-2032 offers a detailed analysis of the market based on the following segments:

Based on Patient Age Group:

• Up to 20
• 21 to 35
• 36 to 50
• 51 to 65
• Above 65

The 36 to 50 age group segment holds the top spot in the India Chronic Disease Management Solutions Market, accounting for 29% market share, due to the rising incidence of lifestyle-related conditions emerging during mid-adulthood.

Individuals in this bracket increasingly experience hypertension, diabetes, metabolic disorders, and cardiac risk factors, driven by prolonged work pressure, sedentary workstyles, irregular diets, and limited physical activity. This population also comprises a significant share of India’s workforce, which shows higher digital literacy, stronger health awareness, and greater adoption of technology-enabled monitoring and preventive care solutions.

At the same time, insurers and enterprises are expanding workplace wellness programmes and structured chronic care initiatives for this age group to reduce treatment costs and productivity losses. As a result, demand for AI-enabled risk screening, remote monitoring platforms, and coordinated long-term care ecosystems is particularly high within this segment.

Evidence from the National Family Health Survey (Round 5) based analysis further reinforces this trend, indicating that the 40–49 cohort constitutes the largest share of adults exposed to chronic disease risk, with health complications increasingly concentrated in mid-life. As chronic conditions emerging earlier in adulthood, the 36–50 age group is expected to remain a core user base and key growth driver for digital chronic disease management solutions.

Based on Disease Indication

• Diabetes
  • Cardiovascular Disease (CVD)
  • Chronic Respiratory Diseases
  • Chronic Obstructive Pulmonary Disorders (COPD)
  • Asthma
• Cancer Care Management
• Chronic Kidney Disease (CKD)
• Hypertension / Blood Pressure
• Neurological Disorders (e.g., Alzheimer’s)
• Gastrointestinal Disorders (IBD, IBS)
• Musculoskeletal Disorders
• Other Chronic Conditions

The diabetes category leads the India Chronic Disease Management Solutions Industry, holding 35% market share, due to its rising prevalence, lifelong care needs, and reliance on continuous monitoring. Earlier onset, associated hypertension and cardiac risks, and strong adoption of digital platforms, remote monitoring, and AI-enabled care tools further reinforce its dominant position.

Government-supported screening and public-health initiatives continue to expand the diagnosed patient base, further increasing demand for structured management solutions. For example, the World Health Organization reports that an estimated 77 million adults in India live with type 2 diabetes, while nearly 25 million more are at high risk (prediabetes), with over half remaining undiagnosed, underscoring the urgent need for long-term care engagement.

At the regional level, a government-linked assessment in Ghaziabad recorded a 41% rise in diabetes cases, increasing from 250,000 to 355,000 patients between 2022–23 and 2024–25, reflecting both growing incidence and deeper integration into treatment pathways.

The chronic, high-maintenance nature of diabetes care, coupled with expanding diagnosis, digital accessibility, and coordinated intervention models, reinforces its dominance in the market and will continue to drive sustained adoption of technology-enabled chronic disease management solutions.

India Chronic Disease Management Solutions Market (2026-32): Regional Projection

The India Chronic Disease Management Solutions Market is dominated by the North India region, which holds a commanding 34% share, driven by its large urban population base, higher diagnosed case load, and comparatively stronger healthcare and digital infrastructure.

The region encompasses major urban and healthcare hubs such as Delhi NCR, Punjab, Haryana, Uttar Pradesh, and Uttarakhand, where lifestyle transitions, sedentary work patterns, dietary changes, pollution exposure, and occupational stress have contributed to increased incidence of diabetes, hypertension, cardiovascular disorders, and chronic respiratory diseases.

Evidence from a national systematic review and meta-analysis reports that hypertension prevalence in the Northern zone is approximately 33%, exceeding levels recorded in several other regions of the country, underscoring a disproportionately higher chronic disease burden in this part of India.

Alongside disease exposure, North India benefits from broader screening coverage, better specialist availability, and higher rates of diagnosis, enabling greater entry of patients into structured monitoring and long-term treatment pathways.

Stronger awareness, faster uptake of telehealth and mobile-health tools, and expanding participation from private hospitals, diagnostic chains, and insurer-linked chronic care programmes further strengthen adoption of coordinated disease-management platforms.

The combination of a large patient pool, advanced care capacity, and rapid digital-health integration firmly reinforces North India’s dominant position in the Chronic Disease Management Solutions Market.

Gain a Competitive Edge with Our India Chronic Disease Management Solutions Market Report 

• India Chronic Disease Management Solutions Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions. 
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition. 
• India Chronic Disease Management Solutions Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.